Great Basin Scientific Announces Completion of Restructuring of Convertible Notes
17 avr. 2017 09h03 HE
|
Great Basin Scientific, Inc.
Exchanged notes have fixed-price conversion of $3.00 per share, premium of 245% to the closing price on April 13, 2017; Derivative liability eliminated SALT LAKE CITY, April 17, 2017 (GLOBE...
Great Basin Scientific Receives CE Marking for Stool Bacterial Pathogens Panel
12 avr. 2017 07h00 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, April 12, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSND) (the “Company”), a molecular diagnostics company, announced today it has received CE Marking for its...
Great Basin Scientific Announces Restructuring of Convertible Securities
10 avr. 2017 09h08 HE
|
Great Basin Scientific, Inc.
Exchange of securities will eliminate floorless variable-rate convertible securities;provide access to $11.6 million of gross proceeds to fund 2017 growth plans SALT LAKE CITY, April 10, 2017 ...
Great Basin Scientific Announces Date of Effectiveness of Reverse Stock Split
07 avr. 2017 16h01 HE
|
Great Basin Scientific, Inc.
Company to effect stock split on April 10, 2017Stock will trade under the temporary symbol GBSNDSALT LAKE CITY, April 07, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a...
Study Published in PLOS ONE Demonstrates Effectiveness of Great Basin Scientific’s Patented Amplification Suppressor Technology
06 avr. 2017 07h30 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, April 06, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced that a research article, “A Novel Approach to Eliminate...
Great Basin Scientific Receives FDA 510(k) Clearance for Bordetella Direct Test
03 avr. 2017 16h00 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, April 03, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, has received U.S. Food & Drug Administration (FDA) clearance for...
Great Basin Scientific Reports Fourth Quarter and Full Year 2016 Results
22 mars 2017 07h02 HE
|
Great Basin Scientific, Inc.
Company reduces operating costs, improves gross margin and cash burn rate quarter-over-quarterFourth quarter revenue increased 39% year-over-year; 2016 revenues increased 42%14% reduction in net cash...
Great Basin Scientific Receives Stockholder Approval for Reverse Stock Split and Authorized Share Increase During Special Meeting
09 mars 2017 20h54 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, March 09, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced that during a special meeting of stockholders held today,...
Great Basin Scientific’s Suzette Chance Named a 2017 Woman Worth Watching in STEM by Profiles in Diversity Journal
02 mars 2017 07h30 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, March 02, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, announced today that Dr. Suzette Chance, senior director of regulatory...
Great Basin Scientific’s Staph ID/R Blood Culture Panel Clinical Evaluation and Rapid Identification Analysis Published in Journal of Clinical Microbiology
15 févr. 2017 07h30 HE
|
Great Basin Scientific, Inc.
SALT LAKE CITY, Feb. 15, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the Journal of Clinical Microbiology published results...